Detalles de la búsqueda
1.
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(5): 665-677, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33812497
2.
Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial.
Oncologist
; 26(11): 941-949, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34190375
3.
Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus.
Pancreatology
; 21(1): 215-223, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33358592
4.
Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS).
Health Qual Life Outcomes
; 19(1): 38, 2021 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33516211
5.
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Oncologist
; 23(4): 422-432, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29330208
6.
Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma.
Int J Colorectal Dis
; 32(8): 1179-1190, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28424871
7.
Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience.
Future Oncol
; 13(7): 615-624, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27802780
8.
Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development.
Cancer Metastasis Rev
; 34(4): 823-42, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26433592
9.
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program.
BMC Cancer
; 16(1): 858, 2016 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27821081
10.
Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS).
Ann Surg Oncol
; 22(9): 2948-57, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25608769
11.
Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.
BMC Cancer
; 15: 495, 2015 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26138480
12.
MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer.
BMC Cancer
; 14: 656, 2014 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25197016
13.
Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).
Neuroendocrinology
; 98(2): 156-68, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23988576
14.
Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS).
Ther Adv Med Oncol
; 15: 17588359231157645, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37007636
15.
SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022).
Clin Transl Oncol
; 25(9): 2707-2717, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129716
16.
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A.
Signal Transduct Target Ther
; 8(1): 405, 2023 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37875500
17.
Somatostatin analogs for the treatment of neuroendocrine tumors.
Cancer Metastasis Rev
; 30 Suppl 1: 9-17, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21369878
18.
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study.
Cancers (Basel)
; 13(4)2021 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33672857
19.
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509).
J Clin Oncol
; 39(20): 2304-2312, 2021 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33945297
20.
Object detection networks and augmented reality for cellular detection in fluorescence microscopy.
J Cell Biol
; 219(10)2020 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32854116